drugset / Trial / NCT04887532
A Trial of HR19042 Capsule in Healthy Chinese Subjects
NaSingle-groupOpen-labelOther
Summary
The study is being conducted to evaluate the safety and pharmacokinetics of HR19042 capsule after single administration in healthy Chinese subjects. To explore the pharmacokinetic characteristics and safety of HR19042 capsule in healthy Chinese subjects.
Timeline
- Start
- 2021-07-01
- Primary completion
- 2021-07-27
- Completion
- 2021-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR19042 | Unknown | 8 mg | — |
| Subject | HR19042 | Unknown | 12 mg | — |
| Subject | HR19042 | Unknown | 16 mg | — |